imtherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* | ||
Meta Tags
| Title | IM |
| Description | Redefining Autoimmunity, Transforming Redefining Autoimmunity, Transforming |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.185.159.145 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
imtherapeutics.com Valuation
|
US$2,455,771
Last updated: 2023-05-07 14:26:08
imtherapeutics.com has Semrush global rank of 4,309,972. imtherapeutics.com has an estimated worth of US$ 2,455,771, based on its estimated Ads revenue. imtherapeutics.com receives approximately 283,359 unique visitors each day. Its web server is located in United States, with IP address 198.185.159.145. According to SiteAdvisor, imtherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,455,771 |
| Daily Ads Revenue | US$2,267 |
| Monthly Ads Revenue | US$68,006 |
| Yearly Ads Revenue | US$816,072 |
| Daily Unique Visitors | 18,891 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| imtherapeutics.com. | A | 599 | IP: 198.185.159.145 |
| imtherapeutics.com. | A | 599 | IP: 198.49.23.144 |
| imtherapeutics.com. | A | 599 | IP: 198.49.23.145 |
| imtherapeutics.com. | A | 599 | IP: 198.185.159.144 |
| imtherapeutics.com. | NS | 3600 | NS Record: ns08.domaincontrol.com. |
| imtherapeutics.com. | NS | 3600 | NS Record: ns07.domaincontrol.com. |
| imtherapeutics.com. | MX | 3600 | MX Record: 10 ALT4.ASPMX.L.GOOGLE.com. |
| imtherapeutics.com. | MX | 3600 | MX Record: 1 ASPMX.L.GOOGLE.com. |
| imtherapeutics.com. | MX | 3600 | MX Record: 5 ALT2.ASPMX.L.GOOGLE.com. |
| imtherapeutics.com. | MX | 3600 | MX Record: 10 ALT3.ASPMX.L.GOOGLE.com. |
| imtherapeutics.com. | MX | 3600 | MX Record: 5 ALT1.ASPMX.L.GOOGLE.com. |
| imtherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:netblocks.dreamhost.com |
| imtherapeutics.com. | TXT | 3600 | TXT Record: v=verifydomain MS=9353187 |
| imtherapeutics.com. | TXT | 3600 | TXT Record: google-site-verification=JfYo6BL2U9BO5PMU2bfb-Z-L03-1_X7R9gnhjc5IhHc |
HtmlToTextCheckTime:2023-05-07 14:26:08
| About Our Platform Therapeutic Focus News Contact Back Company Overview Management Team Board of Directors Scientific Advisory Board Back Overview Our Approach Patient Focus Publications Back Overview Type-1 Diabetes Celiac Disease Other HLA Programs About Company Overview Management Team Board of Directors Scientific Advisory Board Our Platform Overview Our Approach Patient Focus Publications Therapeutic Focus Overview Type-1 Diabetes Celiac Disease Other HLA Programs News Contact Scroll Redefining Autoimmunity, Transforming Lives. Building novel personalized medicines for autoimmune disease with first-of-its-kind targeted drug design and a patient-centered approach Learn more IM Therapeutics is building an HLA-directed platform for new therapies. We have demonstrated early effectiveness in type 1 diabetes and are building a pipeline of targeted therapies across autoimmune diseases. Learn more Our Approach Our novel therapies are designed to specifically block the action of HLA |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 312592 Date: Sun, 24 Oct 2021 14:18:47 GMT Location: https://www.imtherapeutics.com/ Server: Squarespace Set-Cookie: crumb=BcfGX6ptFBAyNmI5NzhmMDQ5NDI1MGM3YjEyNzc1OTBkMThlN2Fj;Path=/ X-Contextid: Hg9wf3JX/ajgGMDJW HTTP/2 200 accept-ranges: bytes age: 241532 content-type: text/html;charset=utf-8 date: Mon, 25 Oct 2021 10:03:07 GMT etag: W/"fbf0dbaaf02377962ec4332a71414248--gzip" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BYHk1gvqdGr+NTgwMzkwYTgzYjUzYjM1Mjg1YTMyMWIyZDFkYWUz;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: nVm2gxRl/47RQeVQd |
imtherapeutics.com Whois Information
Domain Name: IMTHERAPEUTICS.COM Registry Domain ID: 1938878931_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-06-16T12:52:34Z Creation Date: 2015-06-15T18:14:02Z Registry Expiry Date: 2022-06-15T18:14:02Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS07.DOMAINCONTROL.COM Name Server: NS08.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T22:49:30Z <<< |